Search research articles
Contact Us
Filters
Showing results (1-10 of 146) with videos related to
Page
of 15
Sort By:
Gastroenterology & Hepatology
|
May 4, 2022
De-escalation of Therapy for Patients With Inflammatory Bowel Disease
Ryan C Ungaro
Current Research in Pharmacology and Drug Discovery
|
December 26, 2022
Editorial/introduction to special issue
Joana Torres, Ryan C Ungaro
Therapeutic Advances in Gastroenterology
|
June 20, 2023
Managing IBD in the COVID-19 era
Nicholas Scalzo, Ryan C Ungaro
The Lancet. Gastroenterology & Hepatology
|
February 5, 2022
Treat to target with ustekinumab for Crohn's disease
Ryan C Ungaro, Jean-Frederic Colombel
Gastroenterology
|
September 26, 2022
Reappraisal of Coronavirus Disease 2019 Risk for Patients With Inflammatory Bowel Disease: Withdrawal of the British Society of Gastroenterology Inflammatory Bowel Disease Risk Grid
Ryan C Ungaro, Michael D Kappelman
Gastroenterology & Hepatology
|
May 4, 2022
Effectiveness and Safety of COVID-19 Vaccines in Patients With Inflammatory Bowel Disease
Emily Spiera, Ryan C Ungaro, Asher Kornbluth
Gastroenterology
|
October 9, 2021
COVID-19 mRNA Vaccine Short-Term Safety in Patients With Inflammatory Bowel Disease
Emily Spiera, Manasi Agrawal, Ryan C Ungaro
Current Research in Pharmacology and Drug Discovery
|
January 6, 2022
Unmet needs in inflammatory bowel disease
Joana Revés, Ryan C Ungaro, Joana Torres
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
March 23, 2021
The Chicago Classification of Pouchitis: An Important Step Toward a Needed Consensus
Maia Kayal, Ryan C Ungaro, Jean-Frederic Colombel
Gastroenterology
|
January 7, 2022
Is Prevention the Best Way to Modify Inflammatory Bowel Disease? How Close Are We?
Joana Torres, Ryan C Ungaro, Jean-Frédéric Colombel
Page
of 15
Search research articles
Search
Showing results (1-10 of 146) with videos related to
Sort By:
Page
of 15
Gastroenterology & Hepatology
|
May 4, 2022
De-escalation of Therapy for Patients With Inflammatory Bowel Disease
Ryan C Ungaro
Current Research in Pharmacology and Drug Discovery
|
December 26, 2022
Editorial/introduction to special issue
Joana Torres, Ryan C Ungaro
Therapeutic Advances in Gastroenterology
|
June 20, 2023
Managing IBD in the COVID-19 era
Nicholas Scalzo, Ryan C Ungaro
The Lancet. Gastroenterology & Hepatology
|
February 5, 2022
Treat to target with ustekinumab for Crohn's disease
Ryan C Ungaro, Jean-Frederic Colombel
Gastroenterology
|
September 26, 2022
Reappraisal of Coronavirus Disease 2019 Risk for Patients With Inflammatory Bowel Disease: Withdrawal of the British Society of Gastroenterology Inflammatory Bowel Disease Risk Grid
Ryan C Ungaro, Michael D Kappelman
Gastroenterology & Hepatology
|
May 4, 2022
Effectiveness and Safety of COVID-19 Vaccines in Patients With Inflammatory Bowel Disease
Emily Spiera, Ryan C Ungaro, Asher Kornbluth
Gastroenterology
|
October 9, 2021
COVID-19 mRNA Vaccine Short-Term Safety in Patients With Inflammatory Bowel Disease
Emily Spiera, Manasi Agrawal, Ryan C Ungaro
Current Research in Pharmacology and Drug Discovery
|
January 6, 2022
Unmet needs in inflammatory bowel disease
Joana Revés, Ryan C Ungaro, Joana Torres
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
March 23, 2021
The Chicago Classification of Pouchitis: An Important Step Toward a Needed Consensus
Maia Kayal, Ryan C Ungaro, Jean-Frederic Colombel
Gastroenterology
|
January 7, 2022
Is Prevention the Best Way to Modify Inflammatory Bowel Disease? How Close Are We?
Joana Torres, Ryan C Ungaro, Jean-Frédéric Colombel
Page
of 15